 |
| |
 |
Date:05-May-2024 Time: 11:05 PM |
|
 |
 |
 |
|
|
|
|
|
|
| |
| |
| Prospectus Synopsis |
|
Akums Drugs & Pharmaceuticals Ltd
|
| Registered Office:
304 Mohan Place LSC Saraswati
,
Vihar
,
Delhi
-
110034
,
Delhi
, India.
|
|
|
Phone:+91 11 6904 1000 Fax:
|
|
Email:
cs@akums.net
Website:
www.akums.in
|
|
Initial public offer of up to [*] equity shares of face value of Rs. 2 each ("Equity Shares") of Akums Drugs and Pharmaceuticals Limited ("Company" or "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to
Rs. [*] crores comprising a fresh issue of up to [*] equity shares aggregating up to Rs. 680.00 crores by the company ("Fresh Issue") and an offer for sale of up to 18,598,365 equity shares aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders, comprising up to 2,145,965 equity shares aggregating up to Rs. [*] crores by Sanjeev Jain, up to 2,145,965 equity shares aggregating up to Rs. [*] crores by Sandeep Jain (together the "Promoter Selling Shareholders") and up to 14,306,435 equity shares aggregating up to Rs. [*] crores by Ruby QC Investment Holdings Pte. Ltd. (The "Investor Selling Shareholder") (the promoter selling shareholders and the investor selling shareholder, collectively referred to as the "Selling Shareholders") ("Offer for Sale", together with the fresh issue, the "Offer").
This offer includes a reservation of up to [*] equity shares aggregating up to Rs. [*] crores for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer will constitute [*]% and [*]% of its post-offer paid-up equity share capital, respectively.
The company, in consultation with the brlms, may consider a private placement of up to 20% of the fresh issue or such other amount as may be allowed under applicable law for cash consideration aggregating up to
Rs. 136.00 crores, with the roc. The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is undertaken, the minimum offer size (comprising the fresh issue so reduced by the amount raised from the pre-ipo placement, and the offer for sale) shall constitute at least 10% of the post-offer paid-up equity share capital of the company.
The face value of equity shares is Rs. 2 each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be decided by the company.
|
| Issue |
Money Payable On |
| Opens On |
Closes On |
Application |
Allotment |
| NA |
NA |
Rs
0.00-0.00
|
Rs
0.00-0.00
|
| Minimum Application for shares in Nos :
0
Further Multiples of :
0
|
| |
Rs Cr |
Lead Managers to the Issue |
| Project Cost |
0.00 |
ICICI Securities Ltd |
| Project Financed through Current Offer |
0.00 |
|
| Post Issue Equity Share Capital |
0.00 |
|
| Issue Price |
Rs.
0.00
|
|
|
|
|
| |
| Projects |
|
Repayment/prepayment of all or certain borrowings of the company and subsidiary
.
|
Funding incremental working capital requirements of the company
.
|
|
Pursuing inorganic growth initiatives through acquisitions
.
|
General corporate purposes
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|